Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 04 August 2011

Condition: Osteogenesis Imperfecta
Interventions: Drug: BPS804; Other: Untreated reference group
Sponsor: Novartis Pharmaceuticals
Recruiting - verified August 2011

Details: Last Updated: 04 August 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies